Generic drugs saved $482 billion in U.S. healthcare spending in 2024, making up 90% of prescriptions but only 12% of costs. Biosimilars are the next frontier, with potential to save hundreds of billions more-if barriers to entry are removed.
Jan 28 2026
Medicare Part D saves billions by prioritizing generic drugs through tiered formularies, low copays, and caps on out-of-pocket spending. Learn how the system works-and how to use it to cut your prescription costs.
Jan 17 2026
India and China dominate the global generic drug market, supplying affordable medicines worldwide. India leads in volume and speed, while China controls raw ingredients and is moving into high-value biologics. Emerging economies like Vietnam and Cambodia are carving out niche roles in this complex supply chain.
Jan 16 2026
The 80-125% rule ensures generic drugs are absorbed the same way as brand-name versions. It's not about ingredient amount - it's about how your body processes the drug. Learn how regulators use pharmacokinetics and confidence intervals to guarantee safety and effectiveness.
Dec 29 2025
Infographics about generics help patients understand that generic drugs are just as safe and effective as brand-name versions. These visual tools break down FDA approval, bioequivalence, and cost savings to reduce fear and increase use.
Dec 26 2025
Find out which prescription drugs have authorized generics in 2025-exact copies of brand-name medications sold at lower prices. Learn how they work, why they matter, and which ones are available.
Dec 21 2025
Long-term care insurance doesn't cover generic drugs in nursing homes. Learn how Medicare Part D, Medicaid, and out-of-pocket payments actually pay for prescriptions-and what to do to avoid coverage gaps.
Dec 18 2025
Generic medications work just as well as brand-name drugs but cost up to 85% less. Learn why switching is safe, effective, and smart-backed by FDA data, real patient results, and major medical organizations.
Nov 20 2025